Leveraging Tactical Considerations in Pharma to Balance LDT Regulation & CDx Development to Ease Regulatory Pressures

Time: 11:30 am
day: day 1

Details:

  • How could LDTs play a role in supporting global testing and scaling up CDx development?
  • Assessing the risk and benefits associated with relying on LDTs for testing purposes
  • Debating the business case for pharmaceutical companies to develop CDx in the context of regulatory changes and potential labelling requirements

Speakers: